Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24065927 | 0.83 | CHRM2 (0.34) | MEN1LMNAKMT2ACHRM2CHRM4 | |
| SCHEMBL14342995 | 0.83 | CHRM2 (0.34) | MEN1LMNAKMT2ACHRM2CHRM4 | |
| SCHEMBL7100587 | 0.83 | ALDH1A1 (0.39) | MEN1LMNAKMT2ACHRM2CHRM4 | |
| SCHEMBL2959769 | 0.82 | MEN1 (0.46) | MEN1LMNAKMT2ACHRM2CHRM4 | |
| SCHEMBL14063492 | 0.80 | MEN1 (0.33) | MEN1LMNAKMT2ACHRM2CHRM4 | |
| SCHEMBL3262866 | 0.78 | MEN1 (0.35) | MEN1LMNAKMT2ACHRM2CHRM4 | |
| SCHEMBL6113955 | 0.77 | CTDSP1 (0.33) | MEN1LMNAKMT2ACHRM2CHRM4 | |
| SCHEMBL9598615 | 0.77 | MEN1 (0.31) | MEN1LMNAKMT2ACHRM2CHRM4 | |
| SCHEMBL9597774 | 0.77 | MEN1 (0.31) | MEN1LMNAKMT2ACHRM2CHRM4 | |
| SCHEMBL15628015 | 0.77 | MEN1 (0.31) | MEN1LMNAKMT2ACHRM2CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050282710-A1 | Substituted benzoylcyclohexanediones as herbicides | BAYER CROPSCIENCE GMBH (DE) | 2005-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050282710-A1 | Substituted benzoylcyclohexanediones as herbicides | DDT, CBR1, CBR3 | MEN1 3894/4885LMNA 4053/4885KMT2A 2007/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.